{"id":"https://openalex.org/W4362547481","doi":"https://doi.org/10.1158/1535-7163.22498212","title":"Supplementary Figure 3 from Peptidomimetic Src/Pretubulin Inhibitor KX-01 Alone and in Combination with Paclitaxel Suppresses Growth, Metastasis in Human ER/PR/HER2-Negative Tumor Xenografts","display_name":"Supplementary Figure 3 from Peptidomimetic Src/Pretubulin Inhibitor KX-01 Alone and in Combination with Paclitaxel Suppresses Growth, Metastasis in Human ER/PR/HER2-Negative Tumor Xenografts","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362547481","doi":"https://doi.org/10.1158/1535-7163.22498212"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22498212","doi":"https://doi.org/10.1158/1535-7163.22498212","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22498212","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_3_from_Peptidomimetic_Src_Pretubulin_Inhibitor_KX-01_Alone_and_in_Combination_with_Paclitaxel_Suppresses_Growth_Metastasis_in_Human_ER_PR_HER2-Negative_Tumor_Xenografts/22498212/1/files/39956580.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_3_from_Peptidomimetic_Src_Pretubulin_Inhibitor_KX-01_Alone_and_in_Combination_with_Paclitaxel_Suppresses_Growth_Metastasis_in_Human_ER_PR_HER2-Negative_Tumor_Xenografts/22498212/1/files/39956580.pdf","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089006643","display_name":"Muralidharan Anbalagan","orcid":"https://orcid.org/0000-0001-5797-7558","observed_orcids":["https://orcid.org/0000-0001-5797-7558"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Muralidharan Anbalagan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033533097","display_name":"Alaa E. Ali","orcid":"https://orcid.org/0000-0003-0437-8919","observed_orcids":["https://orcid.org/0000-0003-0437-8919"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alaa Ali","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109602292","display_name":"Ryan K. Jones","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ryan K. Jones","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061357744","display_name":"Carolyn G. Marsden","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carolyn G. Marsden","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114046422","display_name":"Mei Sheng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mei Sheng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004454814","display_name":"Latonya Carrier","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Latonya Carrier","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111537798","display_name":"Yahao Bu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yahao Bu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016700895","display_name":"David G Hangauer","orcid":"https://orcid.org/0000-0002-0497-369X","observed_orcids":["https://orcid.org/0000-0002-0497-369X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Hangauer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5014408610","display_name":"Brian G. Rowan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian G. Rowan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.7261000275611877,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.7261000275611877,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.15189999341964722,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.03830000013113022,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/src-inhibitors","display_name":"Src kinase inhibitor","score":0.6819999814033508},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.984000027179718},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7889999747276306},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.753000020980835},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.8379999995231628},{"id":"https://openalex.org/keywords/metastasis-inhibition","display_name":"metastasis suppression","score":0.8119999766349792},{"id":"https://openalex.org/keywords/tumor-growth","display_name":"tumor growth","score":0.7080000042915344},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.8650000095367432}],"concepts":[{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.7575944066047668},{"id":"https://openalex.org/C124790011","wikidata":"https://www.wikidata.org/wiki/Q2069797","display_name":"Peptidomimetic","level":3,"score":0.5190209150314331},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.5158733129501343},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.49495381116867065},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45544978976249695},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4541151523590088},{"id":"https://openalex.org/C2994423619","wikidata":"https://www.wikidata.org/wiki/Q9103","display_name":"Human breast","level":4,"score":0.42262333631515503},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34122204780578613},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3307154178619385},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.1815868318080902},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.17062431573867798},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.1465613842010498},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.04745173454284668},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.22498212","doi":"https://doi.org/10.1158/1535-7163.22498212","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22498212","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_3_from_Peptidomimetic_Src_Pretubulin_Inhibitor_KX-01_Alone_and_in_Combination_with_Paclitaxel_Suppresses_Growth_Metastasis_in_Human_ER_PR_HER2-Negative_Tumor_Xenografts/22498212/1/files/39956580.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22498212","doi":"https://doi.org/10.1158/1535-7163.22498212","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22498212","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_3_from_Peptidomimetic_Src_Pretubulin_Inhibitor_KX-01_Alone_and_in_Combination_with_Paclitaxel_Suppresses_Growth_Metastasis_in_Human_ER_PR_HER2-Negative_Tumor_Xenografts/22498212/1/files/39956580.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362547481.pdf","grobid_xml":"https://content.openalex.org/works/W4362547481.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2144368667","https://openalex.org/W4392681324","https://openalex.org/W2025237375","https://openalex.org/W4361237712","https://openalex.org/W4388111886","https://openalex.org/W4361237747","https://openalex.org/W7095121378","https://openalex.org/W2795015007","https://openalex.org/W1567842620","https://openalex.org/W1505813186"],"abstract_inverted_index":{"PDF":[0],"file,":[1],"388K,":[2],"The":[3,40],"body":[4],"weights":[5],"of":[6],"mice":[7],"were":[8,34,42],"measured":[9],"either":[10],"once":[11],"in":[12],"a":[13],"week":[14],"or":[15],"10":[16],"days":[17],"after":[18],"treatment":[19],"with":[20],"vehicle,":[21],"KX-01,":[22],"PAX":[23],"and":[24,38],"KX-01":[25],"+":[26],"PAX.":[27],"Tumors":[28],"obtained":[29],"from":[30],"tumor":[31],"xenograft":[32],"studies":[33],"fixed,":[35],"paraffin":[36],"embedded":[37],"sectioned.":[39],"slides":[41],"stained":[43],"for":[44],"H&E.":[45]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-06T00:00:00"}